FDA puts the brakes on widening access to COVID-19 plasma treatments, at least for now

Stuart Hall of Buford, Georgia, believes that donated plasma saved his life. Tens of thousands of COVID-19 patients have received infusions of convalescent plasma collected from other coroanvirus survivors. But, the U.S. Food and Drug Administration hasreportedly chosen not to issue an emergency use authorization, which would widen the use of donor plasma, until there is more scientific evidence the treatment is effective.